Indogulf Cropsciences (IGCL): Company Update
Company Update Earnings Call Presentation of the Company pertaining to Q4 of FY 2025-26 Earnings Call Presentation of the Company pertaining to Q4 of FY 2025-26
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
73 articles published
Results for “SCI” · in Market Updates — Clear filters
Company Update Earnings Call Presentation of the Company pertaining to Q4 of FY 2025-26 Earnings Call Presentation of the Company pertaining to Q4 of FY 2025-26
Read articleCompany Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.
Read articlePress Release Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA". Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority
Read article💹 Change: ▼ -2.34% 💰 Price: ₹268.90 📊 Volume: 2.41M 🔍 What's happening? Unusual trading activity detected! This could signal a potential breakout or significant news impact. 💡 Pro Tip: Always conduct thorough research before making investment decisions.
Read articleSuven Life Sciences (SUVEN) stock fell 0.71% to ₹273.40 with 2.22 million shares traded, signaling unusual trading activity on Tuesday.
Read articleSuven Life Sciences (NSE: SUVEN) announced positive findings from a DSMB safety review and interim analysis of its ongoing global Phase 3 study of Masupirdine for Alzheimer's Disease Agitation.
Read articleBayer CropScience has published its audited financial results for the financial year ended March 31, 2026, via official BSE disclosure as per SEBI regulations.
Read articleZydus VTEC Limited, the wholly owned subsidiary of Zydus Lifesciences, has received a Demand Order-In-Original from the Deputy Commissioner of CGST & Central Excise based in Ahmedabad North Commissionerate.
Read articleNSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.